| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C0003062> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C0013218> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C0041703> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C0041714> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C0162692> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C0162693> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C0162694> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C0162695> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C0162696> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C2713498> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C2717829> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C2936405> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C3661486> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33270490_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'CRF, Mass Spectrometry Laboratory, Kusuma School of Biological Sciences (KSBS), Indian Institute of Technology, Delhi, India.\', \'Department of Medicine, Loyola University Medical Center, Chicago, IL, USA.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Kunamneni_Adinarayana> <https://research.tib.eu/covid-19/entity/Sharma_Divakar>
?:doi	10.1080/14787210.2021.1860020
?:doi	<https://research.tib.eu/covid-19/entity/10.1080/14787210.2021.1860020>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Expert review of anti-infective therapy
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33270490> <https://research.tib.eu/covid-19/entity/dfj95gev>
?:pmid	<https://research.tib.eu/covid-19/entity/33270490>
?:pmid	33270490
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.264
?:rankingScore_hIndex	62
?:title	Recent progress in the repurposing of drugs/molecules for the management of COVID-19.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33270490>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33270490>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all